A Gain-of-Function Mutation in TRPA1 Causes Familial Episodic Pain Syndrome

Barbara Kremeyer, Francisco Lopera, James J. Cox, Aliakmal Momin, Francois Rugiero, Steve Marsh, C. Geoffrey Woods, Nicholas G. Jones, Kathryn J. Paterson, Florence R. Fricker, Andres Villegas, Natalia Acosta, Nicolas G. Pineda-Trujillo, Juan Diego Ramirez, Julian Zea, Mari-Wyn Burley, Gabriel Bedoya, David L. H. Bennett, John N. Wood, Andres Ruiz-Linares

    Research output: Contribution to journalArticlepeer-review

    369 Citations (Scopus)

    Abstract

    Human monogenic pain syndromes have provided important insights into the molecular mechanisms that underlie normal and pathological pain states. We describe an autosomal-dominant familial episodic pain syndrome characterized by episodes of debilitating upper body pain, triggered by fasting and physical stress. Linkage and haplotype analysis mapped this phenotype to a 25 cM region on chromosome 8q12-8q13. Candidate gene sequencing identified a point mutation (N855S) in the S4 transmembrane segment of TRPA1, a key sensor for environmental irritants. The mutant channel showed a normal pharmacological profile but altered biophysical properties, with a 5-fold increase in inward current on activation at normal resting potentials. Quantitative sensory testing demonstrated normal baseline sensory thresholds but an enhanced secondary hyperalgesia to punctate stimuli on treatment with mustard oil. TRPA1 antagonists inhibit the mutant channel, promising a useful therapy for this disorder. Our findings provide evidence that variation in the TRPA1 gene can alter pain perception in humans.
    Original languageEnglish
    Pages (from-to)671 - 680
    Number of pages10
    JournalNeuron
    Volume66
    Issue number5
    DOIs
    Publication statusPublished - Jun 2010

    Fingerprint

    Dive into the research topics of 'A Gain-of-Function Mutation in TRPA1 Causes Familial Episodic Pain Syndrome'. Together they form a unique fingerprint.

    Cite this